Real-World Outcomes after Switch to Aflibercept 8 mg in Neovascular AMD: Twelve Months Follow-up on 654 Eyes.

چکیده

To evaluate 12-month outcomes following systematic switch to aflibercept 8 mg in previously treated eyes with age-related neovascular macular degeneration (nAMD). Eyes in a plateau phase (≥10 prior anti-VEGF injections) that were switched to aflibercept 8 mg were retrospectively evaluated.…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• درمان های ضد VEGF
• دژنراسیون ماکولا